COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,318,013 | -56.9% | 403,062 | -33.8% | 0.01% | -58.8% |
| Q4 2022 | $3,060,936 | +120.7% | 608,536 | 0.0% | 0.02% | +142.9% |
| Q3 2022 | $1,387,000 | -14.0% | 608,536 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $1,613,000 | +93.4% | 608,536 | 0.0% | 0.01% | +166.7% |
| Q1 2022 | $834,000 | -67.9% | 608,536 | -25.7% | 0.00% | -57.1% |
| Q4 2021 | $2,595,000 | – | 818,745 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
| CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
| Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
| Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
| Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
| Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
| CAXTON CORP | 86,773 | $170,942 | 0.65% |
| Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
| BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
| Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |